Intrauterine devices and adolescents

被引:27
作者
Gold, Melanie A. [1 ,2 ]
Johnson, Lisa M. [3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pediat, Div Adolescent Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Div Student Affairs, Student Hlth Serv, Pittsburgh, PA USA
[3] Dept Publ Hlth, Nassau, NP, Bahamas
关键词
adolescents; expulsion; infertility; intrauterine contraception; intrauterine device; pelvic inflammatory disease; pregnancy prevention;
D O I
10.1097/GCO.0b013e32830a98f8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of review The purpose of this review is to inform the reader of new information published on intrauterine devices (IUDs) and adolescents. Recent findings There are few studies on the use of IUDs in adolescents. The article reviews topics related to IUD use such as adolescents' knowledge of and attitudes toward IUDs, mechanism of action of copper-releasing and levonorgestrel-releasing IUDs, benefits of using IUDs with adolescents, safety, side effects, as well as noncontraceptive benefits such as management of menstrual disorders and endometriosis using IUDs. Summary IUDs are a safe and effective long-term contraceptive method with no increase in risk of pelvic inflammatory disease, tubal infertility or ectopic pregnancies. IUDs are underutilized in the United States, especially by adolescents. Because adolescents contribute disproportionately to the epidemic of unintended pregnancy, lUDs should be considered as a first-line contraceptive choice regardless of parity. The levonorgestrel-releasing intrauterine system (LNG IUS) is a particularly good choice for adolescents because of associated noncontraceptive benefits such as decreased menstrual bleeding, dysmenorrhea and pain associated with endometriosis. There is a clear need for further studies in the use of the IUD among adolescents.
引用
收藏
页码:464 / 469
页数:6
相关论文
共 48 条
[1]  
ACOG Committee on Practice Bulletins--Gynecology, 2000, Int J Gynaecol Obstet, V71, P183
[2]   Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis [J].
Al-Jefout, Moamar ;
Palmer, John ;
Fraser, Ian S. .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2007, 47 (03) :247-249
[3]  
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, 2006, Obstet Gynecol, V107, P1479
[4]   LEVONORGESTREL-RELEASING AND COPPER-RELEASING (NOVA T) IUDS DURING 5 YEARS OF USE - A RANDOMIZED COMPARATIVE TRIAL [J].
ANDERSSON, K ;
ODLIND, V ;
RYBO, G .
CONTRACEPTION, 1994, 49 (01) :56-72
[5]  
[Anonymous], 2004, J FAM PLAN REPROD H, V30, P99
[6]  
[Anonymous], 2007, Obstetrics Gynecology, V110, P1493
[7]   Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women [J].
Arruda, MS ;
Petta, CA ;
Abrao, MS ;
Benetti-Pinto, CL .
HUMAN REPRODUCTION, 2003, 18 (04) :756-759
[8]  
*BAY HEALTHC PHARM, MIR LEV REL INTR SYS
[9]   COMBINED HYSTEROSCOPIC AND LAPAROSCOPIC FINDINGS IN PATIENTS WITH CHRONIC PELVIC PAIN [J].
CARTER, JE .
JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 1994, 2 (01) :43-47
[10]  
*DUR PHARM INC, PAR T380 INTR COPP C